Quality of life after treatment for head and neck cancer associated with longer-term survival

	Tweet

Quality of life measured one year after treatment for head and neck cancer appears to be associated with longer-term survival, according to a study in the January issue of Archives of Otolaryngology - Head & Neck Surgery.

Several studies have provided evidence that quality of life (QOL) might be associated with long-term survival in cancer patients, according to background information in the article. However, many studies have examined QOL in patients whose cancers were advanced and were in palliative care, so their results might not apply to people undergoing treatment to cure their cancer. Previous studies on head and neck cancer patients had assessed their QOL before they entered treatment and found no association with survival, the authors report.

Hisham M. Mehanna, B.Med.Sc. (Hon), M.B. Ch.B. (Hon), F.R.C.S., of University Hospitals Coventry and Warwickshire, England, and Randall P. Morton, M.B., B.S., M.Sc., F.R.A.C.S., Auckland City Hospital, New Zealand, assessed whether pretreatment and post-treatment QOL is associated with long-term survival in patients with head and neck cancers.

A group of 200 consecutive patients with these types of cancers completed a QOL questionnaire when they were diagnosed with their disease, and again 12 months later, after treatment, if they were free of recurrent cancer.

After 10 years, 136 (68 percent) of the patients died, 48 were alive and the status of 16 was unknown. Those who had a lower QOL one year after treatment--as well as those who had head and neck pain--were more likely to have died.

“We hypothesized that, intuitively, it is more likely that the steady-state QOL, after patients had adjusted to the effects of the diagnosis and of treatment and had mobilized their coping strategies accordingly, would be the determinant of long-term survival, rather than pretreatment QOL,” the authors report. “This was based on the observations that QOL status usually decreases noticeably during and in the period immediately after treatment and that patients return to a steady-state QOL at about one year after diagnosis. The findings of this study seem to corroborate this premise.”

“However, the observed associations between survival benefit and one-year QOL may be confounded by comorbidity, which was not measured and deserves further investigation,” they conclude.

http://archotol.ama-assn.org/

RELATED STORIES:
Fruit, veggies may lower head and neck cancer risk   HK surgeons upbeat on brain cancer removal method   Physical activity in adolescence associated with decreased risk of brain cancer in adulthood   Signaling System Found that Halts the Growth of a Childhood Brain Cancer   Convergence in head and neck cancer   Brain trouble often persists after brain cancer   Certain head and neck cancer patients benefit from second round of treatment   Head & neck cancer in transplant patients: For better or worse?   Rare Head and Neck Cancer Linked to HPV   BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer   HIV-positive head and neck cancer patients benefit from radiation therapy   A Crystal Ball for Brain Cancer?   A new radiation therapy treatment developed for head and neck cancer patients   New treatment combination proves safe, effective for head and neck cancer patients   Minimizing side effects from chemoradiation could help brain cancer patients live longer   Blood Pressure Compound May Benefit Brain Tumor Patients   Cancer Researcher Offer New Hope for Brain Tumor   Customized Virus Kills Brain Tumor Stem Cells that Drive Lethal Cancer   ‘Timing is everything’ in ensuring healthy brain development   Genome code cracked for most common form of pediatric brain cancer   Coffee may cut risk of head and neck cancers   First animal model that mimics human head and neck cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]